Molecular HydroGEN Investment Group, part of the H2 Global Group, has joined forces with VR LIFE. It invested CZK 15 million in the company, which uses virtual reality in healthcare through its VR Vitalis product, and bought a 20% stake. This follows the introduction of the unique combination of the regenerative effects of Molecular Hydrogen and virtual reality and the registration of a joint patent and utility model for this therapy.

Inhalation of molecular hydrogen improves the physical fitness of patients with rheumatic diseases. This is the result of a study that took place for almost 2 years at the Teplice nad Bečvou Spa, which involved experts from Palacký University in Olomouc.